Aytu BioScience, Inc.: Aytu BioScience to Present at Upcoming March Investor Conferences
ENGLEWOOD, CO / ACCESSWIRE / February 24, 2021 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, today announced that Josh Disbrow, Chairman and Chief Executive Officer will present at three upcoming investor conferences in March:
Cowen 41
st Annual Healthcare Conference: A live virtual presentation will occur on Wednesday, March 3, 2021 at 10:20 a.m. ET.
H.C. Wainwright Global Life Sciences Conference: A pre-recorded fireside chat will be available for on-demand viewing beginning at 7:00 a.m. ET on Tuesday, March 9, 2021.
Oppenheimer 31
st Annual Healthcare Conference: A live virtual presentation will occur on Tuesday, March 16, 2021 at 4:30 p.m. ET.
Aytu BioScience to Present at Upcoming March Investor Conferences
phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.
Aytu BioScience to Present at Upcoming March Investor Conferences
theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.
A comprehensive new market research report on
GABA Receptor Agonist market published by DBMR gives details about historic data, present market trends, future product environment, marketing strategies, Strategic recommendations, Competitive Intelligence, emerging trends and the technical progress in the related industry. This intelligence report includes investigations based on Current scenarios, Historical records, and Future predictions. The report contains different market related to market size, trends, segmentation, revenue, production, CAGR, Consumption, gross margin, diagrams, graphs, pie charts, price, and in the post-COVID-19 scenario is projected to grow significantly by 2027. The GABA Receptor Agonist report endows with market potential for each geographical region based on the growth rate, macroeconomic parameters, consumer buying patterns, their preferences for particular product and market demand and supply scenarios. GABA Receptor Agonist market report studies risin